This NDC is on FDA's drug shortage list (posted Feb 8, 2019)
Product Information
DEXAMETHASONE 120 MG/30 ML VL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $0.6940 per ML under NDC 63323016530. Its NADAC has been published 484 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
4 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323016530
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
DEXAMETHASONE SODIUM PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA084916FDA Approved
Before 1982
TE Code
AP
On Market Since
9/7/2000
Pharmacological Classes
Price Statistics
The NADAC for DEXAMETHASONE 120 MG/30 ML VL has been published 484 times since Nov 28, 2013, and over the history we have for it it has risen 21.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6940 per ML |
|---|---|
| All-time high | $1.2543 (Feb 14, 2024) |
| All-time low | $0.4497 (Apr 22, 2026) |
| 52-week high | $0.6943 |
| 52-week low | $0.4497 |
| Median price | $0.9211 |
| Average price | $0.8668 |
| Largest weekly change | -39.0% (Jun 19, 2024) |
| Weeks tracked | 484 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 74% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DEXAMETHASONE SODIUM PHOSPHATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXAMETHASONE 120 MG/30 ML VL?
The current National Average Drug Acquisition Cost (NADAC) for DEXAMETHASONE 120 MG/30 ML VL, manufactured by Fresenius Kabi USA, LLC, is $0.6940 per ML (NDC 63323016530), effective Sep 30, 2026.
How has the price of DEXAMETHASONE 120 MG/30 ML VL changed over time?
Over the history we have for it, the NADAC for DEXAMETHASONE 120 MG/30 ML VL has risen 21.0%. It has been tracked across 484 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DEXAMETHASONE 120 MG/30 ML VL?
Since Nov 28, 2013, the NADAC for DEXAMETHASONE 120 MG/30 ML VL has ranged from a low of $0.4497 (Apr 22, 2026) to a high of $1.2543 (Feb 14, 2024), with a median of $0.9211 per ML.
Are there cheaper alternatives to DEXAMETHASONE 120 MG/30 ML VL?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXAMETHASONE 20 MG/5 ML VIAL, is $0.1807 per ML — about 74% below DEXAMETHASONE 120 MG/30 ML VL.
Who manufactures DEXAMETHASONE 120 MG/30 ML VL?
DEXAMETHASONE 120 MG/30 ML VL (NDC 63323016530) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.
Is DEXAMETHASONE 120 MG/30 ML VL in shortage?
Yes — NDC 63323016530 is currently listed in FDA's drug shortage database (posted Feb 8, 2019).